Abraham Kometz, M.D., who Deerfield's profile refers to as Avi Kometz, is a Partner on the Medical Technologies team and joined the firm in 2014. Before Deerfield he was a Partner at Ascent Biomedical Ventures, where he led investment efforts in biotechnology, pharmaceuticals, medical devices and healthcare information technology. Before Ascent he was head of corporate development at a specialty pharmaceutical company focused on pediatrics, and was a member of the Healthcare Practice at McKinsey & Company in New York. He received his medical doctorate from the University of the Witwatersrand Medical School in South Africa, began his career as a clinician in South Africa and founded and built a group of clinics. Adela, Inc.'s Form D filed 23 April 2026 names him as a Director of the company.
Education
University of the Witwatersrand Medical School, South Africa, medical doctorate
Previous Experience
Clinician in South Africa; founded and built a group of clinics
McKinsey & Company - Healthcare Practice, New York
Specialty pharmaceutical company focused on pediatrics - head of corporate development
Ascent Biomedical Ventures - Partner leading investment efforts in biotechnology, pharmaceuticals, medical devices and healthcare information technology
Notable Investments
Adela, Inc.
Board Seats
Director, Adela, Inc. - Named as a Director in the issuer's Form D filed 23 April 2026. Adela is listed on Deerfield's own portfolio page.
Career Timeline
2014
Joins Deerfield as a Partner on the Medical Technologies team.
2026
Named as a Director of Adela, Inc. in the issuer's Form D filed 23 April 2026.